Scholar Rock Holding Corp — Investor Relations & Filings

Scholar Rock Holding Corp. is a late-stage biopharmaceutical company that discovers, develops, and delivers therapies for serious diseases, with a focus on neuromuscular disorders. The company's scientific approach is centered on selectively targeting protein growth factors in their latent, inactive state. This proprietary platform aims to modulate biological functions with high specificity, representing a novel method compared to traditional approaches that target already activated proteins. Founded on pioneering research from Harvard Medical School and Boston Children's Hospital, Scholar Rock is developing a new class of medicines to address the underlying causes of disease.